Mesoblast

Basic Information

• Category: Clinical-Stage Biotech
• Founded: 2004
• Headquarters: Melbourne, Australia
• Website: mesoblast.com

Documented Facts

• Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
• State of Incorporation: C3 (No linked source recorded for this statement.)
• Stock ticker: MEOBF (OTC) (No linked source recorded for this statement.)

Evidence and Sources

• MESOBLAST LTD — SEC EDGAR (reference)

Citation Guidance

Explore Clinical-Stage Biotech profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Mesoblast.

• Canonical profile: https://brandsource.ai/brands/mesoblast
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/mesoblast/json-ld
• Citation profile API: https://brandsource.ai/api/brands/mesoblast/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Partial
• Profile completeness: Structured profile (68/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2025-10-28T20:51:29.891Z

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Mesoblast is a clinical stage biotech company headquartered in Melbourne, Australia, founded in 2004.

Available profile information

• Official website is captured for entity disambiguation.
• 1 supporting source linked.
• 3 structured facts available for extraction.

Known data gaps

• Profile enrichment is incomplete

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.